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Abstract: By 2015, it is estimated that nearly half of those living with HIV in the US will be 
50 years of age and older. This dramatic change in the demographics of this clinical population 
represents unique challenges for patients, health care providers, and society-at-large. Fortunately, 
because of highly active antiretroviral therapy (HAART) and healthy lifestyle choices, it is now 
possible for many infected with HIV to age successfully with this disease; however, this depends 
upon one’s definition of successful aging. It is proposed that successful aging is composed of 
eight factors: length of life, biological health, cognitive efficiency, mental health, social compe-
tence, productivity, personal control, and life satisfaction. Unfortunately, HIV and medication 
side effects can compromise these factors, thus diminishing one’s capacity to age successfully 
with this disease. This article explores how HIV, medication side effects from HAART, and 
lifestyle choices can compromise the factors necessary to age successfully. Implications for 
practice and research are posited.
Keywords: HIV, AIDS, successful aging, spirituality, depression, hardiness
Introduction
The increased prevalence of HIV in older adults is attributable to three primary 
causes. First, older adults are contracting HIV in later-life. Incidence estimates from 
the Centers for Disease Control and Prevention (CDC) indicate that 15% of all new 
HIV cases occur in person 50 years of age and older.1 The increasing number of older 
adults who are contracting HIV in later life has been primarily attributed to the find-
ing that older adults do not perceive that they are at risk for HIV because HIV has 
often been considered a disease of the young, intravenous drug users, or  homosexuals. 
However, older adults may be more vulnerable to contracting HIV due to certain 
biological changes such as thinner mucosal membranes in the genitalia, anus, and 
vagina that tear more easily during sexual intercourse creating easy access for the 
virus to enter the body.2 Likewise, the introduction of sexual performance enhancing 
medications and establishing new and multiple sexual partnerships in later life due 
to divorce or death of a spouse may result in increased sexual contact and increased 
exposure to HIV.3 Second, the population in general is aging; as the “baby boomers” 
age, by sheer numbers those infected with HIV are also aging which contributes to 
the growing number of older adults with HIV. Third, and most importantly, highly 
active antiretroviral therapy (HAART) introduced in 1996–1997 has been effective 
in preventing viral replication for many patients, resulting in the opportunity for the 
body’s immune system to be reconstituted.4 This allows many adults who respond well 
to such pharmaceutical treatment the chance to live and age with this disease.
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Different mechanistic classes (eg, nucleoside reverse tran-
scriptase inhibitors, non-nucleoside reverse transcriptase inhibi-
tors, protease inhibitors, fusion inhibitors, integrase inhibitors) 
of HIV medications continue to be developed, which means 
that as one combination of medications is no longer effective 
in suppressing viral replication, another combination can often 
be used in order to prolong life.5 As a result, of the 1.1 million 
adolescents and adults in the US infected with HIV, adults 
50 years of age and older account for 24% of those living with 
HIV, 29% of those living with AIDS, and 35% of AIDS-related 
deaths.1 Furthermore, it is estimated that by 2015, nearly half of 
those with HIV in the US will be 50 and older.6 This dramatic 
change in the demographics of the HIV population presents 
unique challenges for patients and health care providers.
The purpose of this article is to provide a general over-
view of the factors related to successful aging as they relate 
to the epidemiology of HIV. Using eight factors from Baltes 
and Baltes’ definition of successful aging: the impact of HIV 
on length of life, biological health, cognitive efficiency, 
mental health, social competence, productivity, personal 
control, and life satisfaction are explored.7 An example of 
how these factors of successful aging interact with HIV is 
provided to show the complexity of aging with HIV. Impli-
cations for clinical interventions are provided along with 
directions for future research. It is important to note that the 
CDC has reported the incidence of HIV using age 50 and 
older as a major category and uses the term “older adult” to 
define those over the age of 50. Therefore, for the purpose 
of this paper, the standard convention of “older” with HIV 
is considered 50 and older.8
Eight factors of successful aging 
with HIV
There are a number of definitions and models of successful 
aging in the gerontological literature;3,9–11 some are very 
simplistic, incorporating only three major factors while 
others have over 20 major and minor factors with various 
interactions between each. Despite their differences, they all 
group certain factors together in biopsychosocial categories 
in order to predict what features are necessary to age suc-
cessfully. Baltes and Baltes proposed a face valid, concrete 
definition of successful aging with eight factors that serve as 
an ideal rubric to explore the issues confronting those aging 
with HIV (Figure 1).7
Length of life
Basically, length of life consists of the number of years one 
remains alive.7 Obviously, being alive longer is a necessary 
factor of aging itself. Likewise, how long one survives into 
“old age” in order to be considered successful is dependent 
on one’s perception of what old age is, and one’s expectation 
for reaching such an age. Some may be pleased to reach their 
70s or 80s, while others specifically aim to see their 90s or 
100s. Such hopes and expectations may be compromised for 
those with HIV. Being infected with HIV, stress from being 
diagnosed with such an expensive and stigmatizing disease, 
and the side effects from HAART can tax biological health 
and reduce life expectancy.
In a sample of 43,355 adults with HIV attending an 
HIV clinic in either North America or Europe, researchers 
examined life expectancy of patients on combination anti-
retroviral therapy during three study periods (ie, 1996–1999, 
2000–2002, 2003–2005). During these time periods, 2056 
(4.7%) of the sample died. From these data, crude mortality 
rates were generated on life expectancy. Life expectancy at 
age 20 was 49.4 (SD = 0.5) years; thus, life expectancy is 
estimated to be approximately two-thirds that of the general 
population. Moreover, life expectancy was lower in men, 
those who contracted HIV through intravenous drug use, and 
those with lower initial baseline CD4+ cell counts.12
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Figure 1 Factors of and obstacles to successful aging with HIV.
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Clearly, HIV does compromise length of life, albeit, these 
data must be interpreted with caution. First, these results are 
based upon data from 1996 to 2005, and since then, additional 
advancements in the treatment of HIV have been made. For 
example, more classes of medications have been developed 
along with a better understanding of HIV. Therefore, it is 
likely that life expectancy for those living with HIV has 
increased and may continue to do so. Second, these results 
are reporting average statistical projections; individual dif-
ferences exist such that some adults with HIV will die sooner 
and others will far exceed the life expectancy reported here. 
Clearly, biological health is compromised which impacts 
life expectancy; however, it is important to be mindful that 
health promoting behaviors such as stress reduction, exercise, 
good nutrition, and substance use and smoking cessation are 
important considerations as well. These behaviors were not 
examined in the aforementioned life expectancy study.
Biological health
Biological health consists of how well the different systems 
of the body (eg, cardiovascular system, limbic system, ner-
vous system) function and interact.7 The immune system is 
compromised by HIV making it less responsive to defend 
against infection. With age, the immune system is compro-
mised by the involution of the thymus; this is important since 
the thymus assists in CD4+ cell maturation.13 Also with age, 
translocation of bacteria between the gastrointestinal mucosa 
and the circulatory system occurs more readily especially 
with alcohol use; this translocation introduces more bacteria 
into the body in which the immune system must fight, which 
thus contributes to early immune senescence.14–17 In fact, one 
study found elevated rates of plasma lipopolysaccharide and 
bacterial DNA (ie, measures of such translocation) in adults 
for at least 2 years after starting HAART.18 Despite these 
obvious ways in which biological health is compromised, 
HIV negatively affects biological health in two other impor-
tant ways: HAART iatrogenic effects and polypharmacy.
First, although HAART has been effective in reducing 
replication of the virus in the body and thus allowing the 
immune system to be reconstituted, for some individuals 
negative side effects of these medications can emerge that 
can be bothersome, uncomfortable, and reduce quality of life, 
but in rare cases, they can even be life-threatening. Although 
such iatrogenic effects do not occur in everyone, when they 
do, they tend to be specific to the type of medication class of 
HAART being used. Nucleoside reverse transcriptase inhibi-
tors are associated with the following iatrogenic effects: ane-
mia, leucopenia, peripheral neuropathy, lactic acidosis, and 
pancreatitis. Non-nucleoside reverse transcriptase inhibitors 
are associated with the following iatrogenic effects: toxic-
ity of the central nervous system, rash, and sleep problems. 
Finally, protease inhibitors are associated with the following 
iatrogenic effects: insulin resistance that can cause type 2 
diabetes, diarrhea, gastrointestinal disorders, lipoatrophy, 
lipohypertrophy, and hyperlipidemia.5,19,20 For this last iatro-
genic effect, medications such as statins are needed to control 
for high cholesterol levels caused by HAART.5
Second, polypharmacy is a concern with aging in gen-
eral, but even more so for adults aging with HIV since 
they are already taking HAART medications that have well 
documented iatrogenic effects. As discussed, these iatrogenic 
effects can produce metabolic syndromes and comorbidities 
that in turn require additional medications. But with advanc-
ing age in general, renal and hepatic diseases are more 
common, with poorer functioning in these systems, and the 
processing and clearance of by-products of these medications 
becomes more difficult, which can further impair biological 
health and lead to the formation of comorbidities.20,21 In a 
study of 1478 outpatients at an HIV clinic, researchers found 
that with age in general, the average number of comorbidities 
rose with each decade of life, with those in their 20s, 30s, 40s, 
50s, and .60s having 2.20, 2.89, 3.96, 4.40, and 4.52 comor-
bidities, respectively. Likewise, they found the average number 
of prescribed medications rose dramatically with each decade 
of life, with those in their 20s, 30s, 40s, 50s, and .60s taking 
7.43, 10.22, 11.72, 12.48, and 14.82 prescribed medications, 
respectively.22 Clearly, the possibility of drug interactions 
also increases with the number of medications taken.
Polypharmacy in older adults with HIV is further com-
plicated by complementary and alternative medicines such 
as herbs and vitamin supplementation that older adults with 
HIV may be taking to augment their biological health. In 
fact, one survey showed that 60% of patients with HIV use 
complementary and alternative medicines to self-treat many 
of their HIV-related issues.23 Unfortunately, some studies 
show that those who use such complementary and alternative 
medicines (eg, vitamin supplementation, herbs, traditional 
healing practices) were less adherent to their medication 
schedules or medical appointments.24,25 Thus, it is essential for 
clinicians to vigilantly monitor polypharmacy and potential 
side effects.
Cognitive efficiency
Cognitive efficiency is defined as the optimal neurological 
integrity necessary to form and process thoughts and ideas, 
remember information, reason, problem solve, and plan 
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in order to effectively negotiate ones’ social and  physical 
 environment.7 Fortunately, due to the effectiveness of 
HAART, HIV-related dementia is much less common than it 
used to be and is now estimated to be prevalent in about 2% 
of this clinical population.26 Regardless, numerous studies 
show that in general, older adults with HIV perform worse on 
cognitive measures (eg, attention, memory, speed of process-
ing, reasoning) compared to same-aged peers without HIV 
and younger adults with HIV.20,27–30 Likewise, these same 
studies also show younger adults with HIV perform worse 
on cognitive measures compared to same-aged peers without 
HIV. This decline in cognitive efficiency is of concern since 
it can negatively affect emotional equilibrium (problem solv-
ing an emotional obstacle) and performance on Instrumental 
Activities of Daily Living (IADLs) such as medication adher-
ence (remembering to take medications), managing finances 
(reasoning how much one owes), and driving (visual speed 
of processing needed to avoid automobile crashes).21
There are many causes of such cognitive declines associ-
ated with HIV and aging. First, HIV creates an inflammatory 
response in the body and the brain that can be damaging to 
neurons.31 Also, reconstitution of the immune system (the 
process of CD4+ cells being regenerated) can also create 
an inflammatory response to the nervous system which can 
negatively impact cognitive functioning.5,32 This problem 
seems to be particularly relevant for those whose CD4+ count 
drops below 200 cells/µL and it appears to have a significant 
and long-term impact on neurological and subsequent cogni-
tive functioning.28,29 Second, past or present substance use 
can obviously interfere with cognitive functioning.21,28,29,31 
Finally, stress, depression, and anxiety have also been shown 
to negatively contribute to cognitive functioning.28,31
In addition to these causes from HIV itself, many adults 
with HIV contend with co-occurring conditions such as 
substance use and hepatitis C infection, which can also 
compromise cognitive functioning. In a study compar-
ing neuropsychological functioning between 187 African 
 American men with HIV to 310 African American men 
without HIV, researchers found that these men with HIV 
performed worse on a number of cognitive measures (eg, 
Grooved Pegboard).33 Furthermore, these researchers catego-
rized this sample into four groups by alcohol use during the 
past 12 months: 1) nondrinkers, 2) light drinkers (,7 drinks/
week), 3) moderate drinkers (7–21 drinks/week), and 4) 
heavy drinkers (.21 drinks/week). Controlling for a number 
of potential confounds (eg, substance use, education), alcohol 
use and HIV serostatus demonstrated an interactive effect. As 
expected, those with HIV who were heavy drinkers exhibited 
poorer cognitive functioning compared to  everyone else. 
Similarly, the use of other drugs (eg, crystal meth, cocaine) 
has also been shown to impair cognitive efficiency in this 
clinical population.28,34 Likewise, hepatitis C coinfection has 
also been shown to further impair cognitive efficiency in 
those with HIV. In a sample of 45 adults with HIV and 20 
adults with both HIV and hepatitis C, researchers found the 
adults with hepatitis C performed worse on measures of fine 
motor functioning and visual memory.35 However, when both 
groups were placed on HAART, differences in their cogni-
tive performance were no longer detected 6 months later. 
 Regardless of this improvement, concerns remain that as 
people with HIV age with substance use issues and/or hepa-
titis C, this may compromise their cognitive efficiency.
Given these main causes, a number of methods have 
been suggested to either prevent cognitive loss or improve 
such cognitive functioning once such declines develop.31 The 
first method suggested is preventing HIV from crossing the 
blood–brain barrier by keeping the amount of the virus in the 
body low through adherence to HAART; having less HIV in 
the circulatory and lymphatic systems means that there will 
be less contact of the virus with the brain, especially glial 
cells which make up 85% of the brain.36 Studies show that 
once HIV crosses the blood–brain barrier, it can infect glial 
cells which support neuronal functioning; once infected, 
the glial cells eventually die and during this process they 
produce quinolic acid, a neurotoxin.36,37 A second method of 
preventing cognitive loss or improving cognition is promot-
ing healthy lifestyle choices such as engaging in physical 
exercise, having good sleep hygiene, reducing stress, eating 
nutritious foods, and avoiding smoking and excessive alco-
hol and drug use. The general tenet is that – what is good 
for the body is also good for the brain, and thus cognition.31 
A third method is treating mood disorders such as anxiety 
and depression. Depression and anxiety are “ruminative” 
disorders; in other words, during these disorders, one rumi-
nates/perseverates (ie, thinks repeatedly) about a particular 
problem(s); this constant focus depletes cognitive resources 
that are needed to perform other cognitive tasks.38 Therefore, 
cognitive abilities are compromised with depression and 
anxiety. Fortunately, studies demonstrate that treating such 
mood disorders with antidepressants actually improves some 
cognitive abilities.39–41
Mental health
Mental health consists of the emotional equilibrium necessary 
to interact effectively with the social and physical environment 
as well as enjoy life.7 Regrettably, HIV has been  associated 
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with poor mental health in two ways: 1) poor mental health 
can predispose one to HIV infection and, 2) a diagnosis of HIV 
can result in poor mental health. First, poor mental health can 
lead to poor judgment and decision-making, which results in 
placing oneself in a situation where exposure to HIV infec-
tion is increased. As shown in numerous studies, those with 
chronic relapsing psychiatric illnesses such as schizophrenia, 
bipolar disorder, and substance abuse are at increased risk of 
HIV infection.42–44 For example, in a sample of 101 adults 
with co-occurring bipolar and substance use disorders, the 
incidence of risky sexual behavior was observed to be quite 
high; 75% reported being sexually active in the last 6 months 
along with high-risk behaviors including unprotected sexual 
intercourse (69%), having sex with multiple partners (39%), 
having sex with prostitutes (24%, men only), and trading sex 
for favors such as money or drugs (10%).45 Clearly, among 
those infected with HIV with severe psychiatric comorbidi-
ties, the extra mental and physical strain of HIV along with 
the neurological impact of HIV on the nervous system will 
possibly make coping with HIV while aging more difficult. 
Hypothetically, with advancing age and the subsequent 
development of mild cognitive impairment and the advance-
ment of early dementia, some individuals with HIV with 
such comorbid psychiatric conditions may experience even 
more compromised judgment. This may result in increased 
risky sexual behavior that may lead to reinfection (ie, being 
re-exposed to a different strain of HIV and/or perhaps a drug-
resistant strain) and further compromise their immune system, 
biological health, and length of life.
Second, HIV is a stigmatizing, life-threatening disease 
often associated with fear, guilt, and uncertainty; thus, a diag-
nosis of HIV can result in intense anxiety, depression, and 
even suicidal ideation. In fact, the prevalence of anxiety and 
depression remains remarkably high across the lifespan, even 
into later life. In the prior study on comorbidity prevalence 
across the life span of 1478 HIV outpatients, the prevalence 
of anxiety in those in their 50s or 60s and greater were 
20.3% and 12.3%, respectively; likewise, the prevalence of 
depression in the same two age groups were 45.8% and 
36.4%, respectively.22 Although these rates are reduced in the 
much older group, this may also reflect survival bias in that 
those who are successfully aging may be hardier in general. 
Clearly, screening and monitoring mood disturbances such 
as these are important mental health issues for patient care, 
but especially for those who may be experiencing extreme 
mood disturbance, specifically suicidal ideation.
Suicidal ideation and suicidal rates are higher in older 
adults (especially men) and those with HIV; therefore, there 
is concern that as people age with HIV, they will be more 
vulnerable to these mental health challenges.38 Following an 
initial HIV diagnosis of 207 women in New York, researchers 
found that 27% and 42% reported attempting suicide within 
the first week and the first month, respectively.46 Based on the 
literature, it appears that over time, the severity of suicidal 
ideation subsides as people learn how to deal with their 
diagnosis but may not subside permanently; when symptoms 
of HIV emerge, such suicidal ideation may increase.47 Since 
comorbidities and other health complications increase with 
age, there is concern that those aging with HIV will also 
experience more suicidal ideation and be at risk for suicide. 
Nichols and colleagues found that out of 172 older adults 
with HIV, 17% considered suicide within the past 6 months.48 
Likewise, in a study of 113 older adults with HIV, 27% 
reported suicidal ideation within the past week.49 Clearly, 
this represents a sizeable minority of older adults with HIV 
vulnerable to these extreme mental health challenges.
Based on this prevalence, it is important to identify 
potential areas that may lead to such anxiety, depression, and 
especially suicidal ideation in those aging with HIV. From 
the literature, a number of stressful factors that may play a 
role in suicidal ideation in this clinical population have been 
identified for intervention; these include changes in appear-
ance (eg, lipoatrophy in the face), HIV-related stigma, age-
ism, declining health, fatigue, neurological changes related 
to poor cognitive functioning, declines in social support 
and loneliness, and financial distress.38 Thus, the following 
recommendations were posited to improve mood and reduce 
negative affect and the prevalence of suicidal ideation; these 
include financial planning to reduce financial distress, learn-
ing to access spiritual supports, counseling, antidepressants, 
and addressing healthy lifestyle choices (eg, exercise, stress 
reduction).
Social competence
Social competence consists of the ability to process social 
interactions constructively to secure physical, emotional, 
and intimate needs.7 From the perspective of social exchange 
theory, being socially competent entails possessing a sense 
of worth in which one can socially exchange with another’s 
worth.50 With a diagnosis of HIV, there often comes a sense 
of being “damaged goods” or “possessing a questionable 
character” that compromises this sense of worth. This dimin-
ished sense of worth can be internalized by the person with 
HIV or externalized by the person with whom he or she is 
socially interacting and exchanging. This diminished worth 
can be further threatened by ageism, homophobia, and/or 
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lack of education or financial means.51 Attractiveness can 
even play a part; those who experience disfiguring of the 
face due to lipoatrophy caused by HAART may experience 
a further loss of social worth.
As social worth decreases, social competence may be 
compromised, and this may result in social withdrawal which 
is often observed with HIV, especially older adults with 
HIV.48 For example, in a sample of 160 older adults with 
HIV, 71% reported living alone, only 47% reported having 
a committed intimate relationship, and 57% reported that 
their emotional needs were unmet. Furthermore, this sample 
reported that their primary social supports were others with 
HIV.52 This becomes particularly germane given that with 
age in general, social networks become smaller due to attri-
tion from poor health, lack of financial resources required 
to engage in social activities (eg, traveling, dining out), and 
death of others in their social network.53
Clearly, social competence is needed to build social sup-
ports and networks that are necessary for successful aging. 
However, the first step is to overcome internalized HIV 
stigma; if an older adult with HIV experiences this, it will 
be difficult to interact and “socially exchange” with others. 
Counseling can be helpful in accepting one’s role as a person 
“who happens to be HIV positive”. Support groups can also 
be a safe place to confront HIV stigma and learn to move 
beyond the diagnosis. Likewise, involvement in supportive 
religious/spiritual communities can also be a source of social 
support and help build one’s social network.
Productivity
Productivity consists of how well one is able to support one’s 
self and one’s goals as well as contribute to group goals.7 
With a diagnosis of HIV, there are often somatic complaints 
such as fatigue, diarrhea, and depression and other health 
issues that interfere or preclude engaging in such goals, one 
of those primary goals being employment for those who are 
not eligible for retirement income.
In a sample of 141 HIV symptomatic gay men in 1995, 
researchers followed them over a 30-month period to observe 
these participants’ change in work status. In general, employ-
ment status for most (79%) of these men was continuous over 
time; they were employed full-time (30%), employed part-
time (9%), or unemployed (40%). For those (31%) whose 
employment status changed from the beginning of this study 
period, they either: increased their hours (13%), decreased 
their hours (8%), terminated employment (4%), or showed a 
wavering pattern (6%). By the end of the study period, 52% 
were either unemployed or were working fewer hours.54 This 
figure represents a particular challenge to successful aging 
since employment is an important source of productivity as 
well as health insurance. Work can be a rich source of iden-
tity and provides contact to interact with others, which can 
help build social networks; also, work is a means of social 
worth. In this study, researchers found that even when the 
health of these men did improve, this did not precipitate a 
return to work. In further analysis of these data, several bar-
riers related to partial employment and unemployment were 
identified including fear of losing disability benefits, physical 
limitations due to health problems, psychiatric problems (ie, 
depression, dysthymia), cognitive problems (ie, executive 
functioning), and lower education level. Although age was 
not an identified barrier in this study, this may be because the 
age of the sample was quite young (M
age
 = 40, SD = 8). Today 
however, age may be an important factor; since many adults 
with HIV are aware that they are aging with this disease, 
the urgency to work and plan for retirement is important, 
especially in lieu of the current economic uncertainty when 
disability benefits and other social assistance programs are 
threatened.
For those aging with HIV, there are a number of chal-
lenges to their productivity, specifically surrounding the 
issues of work, retirement, and being able to support oneself 
financially. First, for many adults aging with HIV, they may 
have been diagnosed in the late 80s and early 90s when poor 
prognoses were dispensed and survival was not expected. As 
such, they may have reduced their work hours and therefore 
received less money, backed away from pursuing careers, 
were sick and needed to go on disability, or opted for early 
retirement. Believing that death was imminent, many may 
have amassed enormous debts in order to live the remainder 
of their days in relative comfort. But with the nascent of 
HAART in the second half of the 90s, optimism for better 
prognoses and expected survival increased. Instead of dying, 
many had to learn to live again; this social phenomenon 
caused by the effectiveness of HAART has been referred 
to as Lazarus Syndrome.55 As a result, many have found 
themselves in one of many precarious financial straits. First, 
some may have sold their life insurance in viatical settlements 
at a reduced rate only to find that they would be paying on 
a policy that is worthless. Second, others may have had to 
face bankruptcy for amassing enormous bills during a time 
they thought they were going to die; thus, their credit is 
severely compromised. And third, some may not have stayed 
employed and received disability benefits or early retire-
ment only to find that years later, in their 50s and 60s, that 
they have much longer to live. However,  living on a fixed 
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income within the context of rising costs and  diminishing 
social programs may not be sufficient to support their life-
style such as it is.
For those who are healthy enough to decide to return to 
work in later life, this option is challenging as well. First, 
for those on disability or retirement, returning to work can 
threaten the continuation of receiving such benefits, even if 
work is part-time. Negotiating part-time or full-time employ-
ment can certainly be a stressful situation requiring a great 
deal of finesse and assistance.54 Second, finding a job can be 
difficult especially when one is older and has an inconsistent 
work history. This situation is further problematic given the 
subtle influence of ageism in the workplace.56,57 Employers 
may be reluctant to hire older adults for several reasons: 
1) they may need retraining and retooling especially in lieu 
of the advancements made in technology, 2) they will prob-
ably retire in a few years, and 3) they may be a burden on the 
company’s health insurance plan.58 These challenges are quite 
real; however, how to confront them remains elusive.
Personal control
Personal control consists of one’s sense of influence over one-
self and his or her environment.7 This concept is intricately 
related to the concept of social competence as well, in that 
personal control is used in a social context to establish social 
worth. But when one is diagnosed with HIV, that sense of 
control is compromised because one can no longer “not” have 
HIV; it is permanent and at this point beyond one’s control 
regardless of any future actions. Likewise, given the stigma-
tizing nature of HIV, one’s social worth is subsequently com-
promised; one is now stigmatized by default. Furthermore, a 
diagnosis of HIV contains uncertainty about if or when one 
will become ill, disabled, or die; this uncertainty is observed 
in many other life-threatening diseases (eg, cancer) as well 
and is referred to as Damocles Syndrome.59
In the story of King Damocles, a servant remarked during 
a banquet that it must be easy to be the king and be waited 
upon. King Damocles responded by having the servant sit 
at the head of the table, removed his sword, tied the hilt of 
the sword to a beam high above the servant’s head using a 
single hair from a horse’s tail. With the point of the sword 
positioned over the servant, King Damocles instructed the 
servant to enjoy the banquet in his stead. Not having control 
over the situation, the servant obviously could not enjoy the 
banquet for fear that the hair would break at any moment, 
allowing Damocles’ sword to fall and impale him.
Such loss of personal control and uncertainty may be 
exacerbated in those who are older with HIV. As mentioned, 
individuals aging with HIV may not be in a position to rally 
adequate financial, social, and physical resources to exert 
control in their lives. This may be further compromised by 
declines in cognitive efficiency and biological and mental 
health. Such a loss of personal control is tantamount to help-
lessness and hopelessness, which may contribute to feelings 
of anxiety, depression, and suicidal ideation.
Coping with such a loss of personal control is an essential 
aspect of successful aging with HIV. Passive and active cop-
ing techniques are ways of dealing with the emotional aspect 
of such helplessness. Passive coping techniques entail miti-
gating negative emotions through avoidance strategies. These 
can be subtle such as watching TV or they can be extreme 
such as abusing alcohol and drugs. While passive coping 
techniques are needed to escape and assuage negative feel-
ings, they do not address the source of the problem. Active 
coping techniques are necessary to address the source of 
negative feelings whether it be fear of developing dementia, 
worry about not having enough money to retire, or concern 
about being alone. Therefore, active coping techniques are 
needed to address such issues whether they be learning more 
about how to stay cognitively efficient, consulting a financial 
advisor, or joining a support group.
Many individuals when f irst diagnosed with HIV 
experience this loss of personal control; this is evident in 
the elevated rate of suicide attempts (42%) within the first 
month of being diagnosed.46 Fortunately, many learn to 
adapt through a combination of passive and active coping 
techniques. Moreover, for some this loss of personal control 
may be reestablished by redefining the extent of their personal 
control. For example, “I may not be able to get rid of HIV, 
but I can take my medications consistently and try to keep a 
positive outlook”. By focusing on what one can “do” or can 
“try”, one reestablishes a sense of personal control. In the 
successful aging literature, this “can do” attitude is known 
as hardiness.
Basically, hardiness refers to the ability to endure nega-
tive stressors. Research demonstrates that hardiness facili-
tates successful aging.60 In fact, some studies even show that 
those who score higher on measures of hardiness have a more 
robust immune system and better psychosocial outcomes 
than those with a lower score.61 Although some researchers 
consider hardiness to be a trait and therefore nonmalleable,62 
others consider it a personal paradigm or perspective.60 As a 
perspective, it is therefore something that can be developed, 
learned, and even unlearned. As such, some researchers have 
suggested individual cognitive-behavioral programs, based 
on principles of motivational interviewing, to help ameliorate 
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hardiness in adults with HIV with the focus on helping them 
to age successfully. Within these programs, individuals set 
their own goals and are instrumental in devising strategies to 
improve their sense of personal control and hardiness as they 
use a combination of passive and active coping  strategies.60 
Clearly, whether it is successful aging with HIV or any 
other life-threatening disease, it is important to develop and 
maintain a sense of personal control in one’s life.
Life satisfaction
Life satisfaction consists of the quality and meaning one 
attributes to his or her existence.7 Although related to the 
concept of personal control in that they are both personal 
perceptions, life satisfaction is a global phenomenological 
concept. Moreover, how much one is satisfied with one’s 
life cannot be reduced into a formulaic statement. In fact, 
one could surmise that life satisfaction is tantamount to the 
concept of successful aging itself. Clearly, length of life, 
biological health, cognitive efficiency, mental health, social 
competence, productivity, and personal control make up a 
part of whether one is satisfied with life, and therefore aging 
successfully. However, one’s perception of life satisfaction 
remains elusive. For example, Mr X, who has been living 
with HIV since the early 80s may have lost several close 
friends and partners, be living on a severely limited fixed 
income, be in poor health and unable to work, does not have 
a partner, yet be quite satisfied with his life and considers 
himself to be aging quite successfully. Meanwhile, Mr Y 
who was diagnosed in 2001 when the efficacy of HAART 
was well-established, is very healthy, exercises every day, 
has a partner and a thriving business, yet despite such pleas-
ant circumstances, is not satisfied with his life and considers 
himself to be aging unsuccessfully. Thus, life satisfaction 
appears to be quite a subjective construct.
Other factors obviously play an important role in deter-
mining whether individuals are satisfied with their lives as 
they age with HIV, such as spirituality. In a mixed-methods 
design, 50 adults with HIV (M
age
 = 40 years; range = 31–56 
years) were assessed on a number of spirituality and health-
related factors. Interestingly, 72% reported that their spiritu-
ality changed after being diagnosed with HIV; furthermore, 
when asked “Do you consider HIV to be a blessing?” 44% 
reported that they did. This was surprising but when asked 
why, many indicated that their HIV diagnosis helped them 
to reprioritize their lives and focus on the things that truly 
matter. Participants were also asked “Do you feel that you 
are aging well?” (1 = not at all; 5 = extremely); as a group, 
they responded within the “moderately” category (M = 3.20; 
SD = 1.21). Further analysis revealed that those who thought 
they were aging successfully were more likely to be those 
whose spirituality changed after being diagnosed with HIV 
(r = 0.33) and reported HIV to be a blessing (r = 0.36).63,64 
From this study, meaning, in this case derived from spiritual-
ity, is important in attributing whether one is aging success-
fully and perhaps satisfied with life.
The complexity of aging with HIV
The factors necessary for successful aging with HIV pre-
sented in Figure 1 are dynamic and interact with each other 
in innumerable ways. An example of this is provided in 
Figure 2. Starting with cognitive efficiency, for some aging 
with HIV, cognitive declines may be ineluctable. Such 
cognitive decline has been observed in the literature to be 
related to poor medication adherence (Path A).65 As a result, 
poor medication adherence can create viral resistance to the 
medication and result in poor biological health (Path B), 
which in turn can shorten one’s length of life (Path C) and 
compromise neurological systems resulting in more cognitive 
decline (Path D). Further exacerbation of cognitive efficiency 
can then subsequently result in decreased social competence, 
productivity, and mental health (Paths E); if one is experienc-
ing cognitive declines, this can interfere with socializing with 
others, poor job performance, and lead to depression. With 
declines in social competence, decreased productivity, and 
mental health, these can interact among themselves to further 
exacerbate these declines (Paths F). For example, increased 
depression and anxiety may interfere with one’s employment 
and lead to social withdrawal. Finally, the collective influence 
of cognitive decline, poor biological health, shorter length 
of life, and decreased social competence, productivity, and 
mental health will negatively affect one’s perception of life 
satisfaction (Paths G).
Implications for clinical  
intervention and research
There are innumerable areas of clinical intervention research 
that should be investigated, but with increasingly limited 
funding and resources, selecting such areas must be made 
judiciously. The definition of successful aging (Figure 1) 
provides scaffolding in which to direct such efforts. The two 
predominant areas for clinical intervention research obviously 
include length of life and biological health; clearly, more is 
needed in drug development and management of comorbidi-
ties in order to help adults live longer and better with this 
disease. Furthermore, with the involution of the thymus with 
age and HIV, looking into new ways to boost thymic function 
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Figure 2 example of the interaction of the factors of successful aging with HIV.
such as sex steroid ablation in order to help the immune system 
function better is an important area of research.13
Now that HIV infection has become a chronic disease for 
many people who tolerate the medications, further emphasis 
must also focus on pharmacological aspects of HIV disease 
management with age-related side effects. Specifically, as 
viral resistance to certain medications develop, it is not 
clear whether older adults with this disease will be able to 
effectively switch to previous medications that years before 
were effective in controlling the virus. Likewise, with aging 
comes poorer hepatic and renal functioning, so how older 
individuals tolerate such HIV medications will need to be 
reexamined since many of these medications were not tested 
with older adults.
Ostensibly, clinical interventions to improve the psycho-
social factors of successful aging must also be considered 
given how they dynamically impact everyday functioning 
and affect biological health and length of life. One area 
of particular need will be clinical interventions to protect 
and improve cognition. Although recommendations for 
improving general cognition through healthy lifestyle 
choices have already been posited, more targeted inter-
ventions to improve certain cognitive abilities should be 
investigated. One pilot study used a pre–post, two-group, 
experimental design to examine whether visual speed of 
processing training improved cognitive functioning in 
52 older participants with HIV (M
age
 = 51.5 years); typi-
cally this cognitive remediation therapy is used in normal 
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community-dwelling older adults to improve their driving 
and instrumental activities of daily living performance.31 
Researchers randomized these participants either into the 
speed of processing (experimental) condition or into a 
no-contact (control) condition. Those in the experimental 
condition received 10 hours of an interactive computer gam-
ing program that was specifically designed to increase the 
rate in which participants processed visual information. Not 
only did this experimental group improve upon a measure 
of visual speed of processing (ie, Useful Field of View® 
test), this transferred to improvements on the Timed Instru-
mental Activities of Daily Living test.66 Such noninvasive, 
nonmedical cognitive interventions are favored, especially 
since they are inexpensive and do not place medication 
demands on a clinical population for which there is already 
a heavy pharmaceutical burden.22
Lipoatrophy of the face as well as the body is another 
important area for research. As mentioned, such fat wasting 
in the face can be extremely devastating in terms of its impact 
on social competence. Lipoatrophy is more common with 
thymide analogs of HAART but also occurs more frequently 
with age. Unfortunately, there are few effective treatments 
for reversing the effects of lipoatrophy and those that exist 
are normally not covered by health insurance.67
Finally, another area in which clinical interventions are 
needed to improve the psychosocial factors of successful 
aging is productivity, specifically financial planning. As 
alluded to earlier, HIV is an expensive disease with medi-
cation costs running into the tens of thousands of dollars 
per year; in lieu of diminishing social programs and public 
assistance, this is an especially difficult hardship for those 
who do not have health insurance. Beyond that, many are 
facing an uncertain retirement, well aware that they do not 
have the means to live at a decent standard of living. This 
is further complicated by the fears of uncertain economic 
conditions that foster severe cutbacks in social programs for 
the indigent, infirm, and elderly. There are no easy answers 
to these mounting concerns; but clearly innovative ideas are 
needed to address what can be done to help individuals age 
with this disease.
Conclusion
Within the past few years, the topic of aging with HIV has 
emerged as one of the leading issues surrounding HIV care. 
At the 18th International AIDS Conference in July 2010, 
over 20,000 HIV scientists, activists, and people living with 
HIV gathered in Vienna, Austria to discuss several of the 
pressing topics surrounding HIV and AIDS care. That year, 
this change in the demographics of aging with HIV was 
recognized with 26 workshops, seminars, and other venues 
focusing on this topic.68 As the population of older adults 
with HIV increases, understanding the factors important 
to facilitate successful aging with this disease will become 
much more important.
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